Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Transitional Cell × Sirolimus × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 18 Lymphoma, Non-Hodgkin 16 Hodgkin Disease 15 Leukemia, Lymphocytic, Chronic, B-Cell 14 Graft vs Host Disease 12 Lymphoma, Mantle-Cell 11 Leukemia 11 Sarcoma 10 Multiple Myeloma 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma 9 Burkitt Lymphoma 9 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Hematologic Neoplasms 7 Congenital Abnormalities 7 Waldenstrom Macroglobulinemia 6 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Accelerated Phase 6 Breast Neoplasms 6 Osteosarcoma 5 Neoplasms 5

Interventions

pembrolizumab 23 Gemcitabine 23 Nivolumab 15 atezolizumab 14 Cisplatin 14 avelumab 12 Carboplatin 11 Docetaxel 10 enfortumab vedotin 8 Paclitaxel 7 durvalumab 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 pemigatinib 5 Specimen Handling 5 vinflunine 4 toripalimab 4 sacituzumab govitecan 4 cabozantinib 4 Taxes 4 cabazitaxel 3 Standard of Care 3 Pemetrexed 3 Injections 3 Everolimus 3 Albumin-Bound Paclitaxel 3 tislelizumab 2 sapanisertib 2 disitamab vedotin 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01856101 2019-04-10

BEZ235

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡